Next Article in Journal
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults
Previous Article in Journal
Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review
 
 
Brief Report

Article Versions Notes

Vaccines 2025, 13(4), 382; https://doi.org/10.3390/vaccines13040382
Action Date Notes Link
article xml file uploaded 3 April 2025 06:13 CEST Original file -
article xml uploaded. 3 April 2025 06:13 CEST Update -
article pdf uploaded. 3 April 2025 06:13 CEST Version of Record -
article supplementary file uploaded. 3 April 2025 06:13 CEST - https://www.mdpi.com/2076-393X/13/4/382#supplementary
article html file updated 3 April 2025 06:14 CEST Original file -
article xml file uploaded 3 April 2025 07:00 CEST Update -
article xml uploaded. 3 April 2025 07:00 CEST Update https://www.mdpi.com/2076-393X/13/4/382/xml
article pdf uploaded. 3 April 2025 07:00 CEST Updated version of record https://www.mdpi.com/2076-393X/13/4/382/pdf
article html file updated 3 April 2025 07:01 CEST Update -
article supplementary file uploaded. 3 April 2025 07:32 CEST - https://www.mdpi.com/2076-393X/13/4/382#supplementary
article html file updated 3 April 2025 07:33 CEST Update https://www.mdpi.com/2076-393X/13/4/382/html
Back to TopTop